About Hologic Timeline HISTORY OF INNOVATION SCROLL TO LEARN MORE 1985 FDA clears the first nucleic acid test. 1987 Hologic introduces the first dual-energy X-ray absorptiometry system for evaluating osteoporosis. 1988 FDA clears the first molecular diagnostic test kit for a sexually transmitted infection. 1995 FDA approves the Rapid fFN® test. 1996 FDA approves the ThinPrep® Pap test, liquid-based cytology for cervical cancer screening. 2001 FDA approves the NovaSure® endometrial ablation treatment for abnormal uterine bleeding (AUB). 2002 FDA approves the Selenia® mammography system–the beginning of a new era in breast cancer screening. 2003 Release of the Tigris® DTS® system for automated screening of sexually transmitted infections (STIs). 2008 FDA approves the Procleix® Ultrio®* triplex blood screening assay for HIV-1, hepatitis B and C. *Procleix and Ultrio are registered trademarks of Grifols, SA. 2011 FDA approves the breakthrough Selenia Dimensions® digital tomosynthesis system with the Hologic 3D Mammography™ exam. 2012 FDA clears the Panther® system, an automated, integrated molecular platform, for use with the Aptima Combo 2® assay. 2014 FDA clears the use of the bone densitometer for assessing three critical health problems, including osteoporosis 2015 CE marked virology portfolio, including Aptima® HIV, HCV and HBV assays, along with the Aptima® M. genitalium assay. 2016 FDA clears the new Affirm® prone biopsy system. 2017 The Brevera® breast biopsy system with CorLumina® imaging technology combines tissue acquisition, real-time imaging, verification and advanced tissue handling. 2018 FDA clears Clarity HD high-resolution 3D™ imaging and the SmartCurve™ breast stabilization system, providing superior image quality and a clinically proven solution for a more comfortable mammogram. The FDA grants clearance to the new Aptima® BV and Aptima® CV/VT assays, which provide an accurate and objective method for diagnosing vaginitis. . 2020 FDA grants Emergency Use Authorization (EUA) for the Panther Fusion® SARS-CoV-2 and Aptima® SARS-CoV-2 assays, molecular diagnostic tests detecting the novel coronavirus. Main navigation (Footer) WOMEN'S HEALTH PRODUCTS LAB TECHNOLOGIES ABOUT SUPPORT CAREERS WOMEN'S HEALTH INDEX Hologic footer logo © Copyright 2021 Hologic, Inc. All rights reserved. Health logo Footer menu Privacy Policy Terms & Conditions Patent Info AdvaMed Code of Ethics International Modern Slavery Statement Footer social links Twitter Linkedin Facebook Glassdoor Youtube Instagram

The content of this site is reserved for medical professionals only. YUP I am a medical professional NO I am not a medical professional Our battle against COVID-19. Find out more . We use cookies on our website to offer you the most relevant experience by remembering your preferences and repeat visits. By clicking on "Accept all" you consent to the use of ALL cookies. However, you can visit "Cookie Settings" to provide controlled consent. Cookie settings Accept all ITALY LOGIN DOWNLOAD AREA PACKAGE INSERTS